Results 101 to 110 of about 10,897,164 (297)

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

High pressure chemical engineering : proceedings of the 3rd International Symposium on High Pressure Chemical Engineering, Zürich, Switzerland, October 7-9, 1996 /

open access: yes, 1996
This present volume contains the text of all contributions (oral and posters), except for the four invited papers, which were presented at the 3rd International Symposium on High Pressure Chemical Engineering on October 7-9, 1996.
Trepp, Ch.   +2 more
core  

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

open access: yesMolecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad   +2 more
wiley   +1 more source

Interest Groups: An Introduction [PDF]

open access: yes
This paper reviews public choice theories of interest groups.Interest groups; rent ...
Filip Palda
core  

National Pressure Groups and Provincial Curriculum Policy: Temperance in Nova Scotia Schools 1880-1930

open access: yesCanadian Journal of Education, 1984
This article explores the support for, the introduction of, and the content in temperance courses in the schools of Nova Scotia between 1880 and 1930. By examining temperance organizations, in particular, the Sons of Temperance and the Woman's Christian
Nancy M. Sheehan
doaj   +4 more sources

Serendipitous Catch of a Giant Jellyfish: An Ionized Nebula around 3C 275.1 with 170 kpc Long Tails

open access: yesThe Astrophysical Journal
3C 275.1 is a blue quasar at z = 0.55522, hosting powerful outflows and residing in a complex environment. We present a serendipitously detected giant nebula surrounding 3C 275.1, which shows morphological features resembling those of objects known as ...
Qinyuan Zhao, Junfeng Wang, Zhenzhen Li
doaj   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy